How AI and robotics will advance interventional radiology: Narrative review and future perspectives
J Zhang, J Fang, Y Xu, G Si - Diagnostics, 2024 - mdpi.com
The rapid advancement of artificial intelligence (AI) and robotics has led to significant
progress in various medical fields including interventional radiology (IR). This review …
progress in various medical fields including interventional radiology (IR). This review …
Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic …
M Avanzo, V Gagliardi, J Stancanello, O Blanck… - Medical …, 2021 - Wiley Online Library
Purpose The aim of this study is to improve the performance of machine learning (ML)
models in predicting response of non‐small cell lung cancer (NSCLC) to stereotactic body …
models in predicting response of non‐small cell lung cancer (NSCLC) to stereotactic body …
[HTML][HTML] Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients
M Li, X Xu, Y Qin, P Zhang, C Shen, Q Xia… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Approximately 20% resectable non-small cell lung cancer (NSCLC) patients
are treated non-surgically due to various reasons. The aim of the present study was to …
are treated non-surgically due to various reasons. The aim of the present study was to …
Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic …
K Bousabarah, S Temming, M Hoevels… - Strahlentherapie …, 2019 - search.proquest.com
Objectives To predict radiation-induced lung injury and outcome in non-small cell lung
cancer (NSCLC) patients treated with robotic stereotactic body radiation therapy (SBRT) …
cancer (NSCLC) patients treated with robotic stereotactic body radiation therapy (SBRT) …
Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two …
K Bousabarah, O Blanck, S Temming, ML Wilhelm… - Radiation …, 2021 - Springer
Objectives To generate and validate state-of-the-art radiomics models for prediction of
radiation-induced lung injury and oncologic outcome in non-small cell lung cancer (NSCLC) …
radiation-induced lung injury and oncologic outcome in non-small cell lung cancer (NSCLC) …
[HTML][HTML] Fiducial marker placement for stereotactic body radiation therapy via convex probe endobronchial ultrasound: a case series and review of literature
BJ Seides, JP Egan III, KD French… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Convex probe endobronchial ultrasound (CP-EBUS) and stereotactic body radiotherapy
(SBRT) are valuable tools in the diagnosis, staging, and treatment of thoracic malignancies …
(SBRT) are valuable tools in the diagnosis, staging, and treatment of thoracic malignancies …
Clinical results of mean GTV dose optimized robotic-guided stereotactic body radiation therapy for lung tumors
R Baumann, MKH Chan, F Pyschny, S Stera… - Frontiers in …, 2018 - frontiersin.org
Introduction We retrospectively evaluated the efficacy and toxicity of gross tumor volume
(GTV) mean dose optimized stereotactic body radiation therapy (SBRT) for primary and …
(GTV) mean dose optimized stereotactic body radiation therapy (SBRT) for primary and …
Radiation-induced dyspnea in lung cancer patients treated with stereotactic body radiation therapy
Simple Summary Dyspnea is a common symptomatic side-effect of thoracic radiation
therapy. The aim of this study is to build a predictive model of any-grade radiation-induced …
therapy. The aim of this study is to build a predictive model of any-grade radiation-induced …
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer
S Sumodhee, PY Bondiau, M Poudenx, C Cohen… - BMC cancer, 2019 - Springer
Background In stage III non-small cell lung cancer (NSCLC) treated with concomitant
chemoradiotherapy, there is a high rate of relapse. Some of these relapses are only local …
chemoradiotherapy, there is a high rate of relapse. Some of these relapses are only local …
Stereotactic ablative radiotherapy using CyberKnife for stage I non-small-cell lung cancer: a retrospective analysis
K Hayashi, O Suzuki, H Shiomi, M Nakai… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: We evaluated the effectiveness and safety of stereotactic ablative
radiotherapy (SABR) delivered using Cyberknife in patients with stage I non-small-cell lung …
radiotherapy (SABR) delivered using Cyberknife in patients with stage I non-small-cell lung …